<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">
<html>&#13;
&#13;
<head>&#13;
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet"/>&#13;
    <link href="./static/css/outliers.css" rel="stylesheet"/>&#13;
    <meta charset="UTF-8"/>&#13;
</head>&#13;
&#13;
<body>&#13;
    <div class="container"><h1>Static outliers for Eskdaill Medical</h1>
<p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
    explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
    prescribers and organisations to audit and review prescribing.</p>
<p>The below reports have been developed to use &#8220;z-scores&#8221; to automatically identify prescribing patterns at a chemical level which are furthest away from &#8220;typical prescribing&#8221; and can be classified as an &#8220;outlier&#8221;. It is important to remember that
    this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
    method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
    We used the time period from 1 April 2021 to 1 August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the &#8220;z-score&#8221;, which is a measure
    of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your &#8220;z-scores&#8221; to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
    for prescribing lower than its peers.</p>
<p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&amp;entry.2016356131=practice+K83013">survey</a>
    or emailing us at
    <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
    feedback.
</p><h2>Prescribing where Eskdaill Medical is higher than most</h2>&#13;
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">&#13;
  <thead>&#13;
    &#13;
    &#13;
  <tr><th>BNF Chemical</th>&#13;
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>&#13;
      <th>BNF Subparagraph</th>&#13;
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>&#13;
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>&#13;
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>&#13;
      <th><abbr title="Standard Deviation">std</abbr></th>&#13;
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>&#13;
      <th>Plots</th>&#13;
    </tr></thead>&#13;
  &#13;
<tbody><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0401010AC&amp;denomIds=4.1.1&amp;selectedTab=summary">Sodium oxybate</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>6</td>&#13;
      <td>Hypnotics</td>&#13;
      <td>677</td>&#13;
      <td>0.01</td>&#13;
      <td>0.0</td>&#13;
      <td>0.00</td>&#13;
      <td>7.80</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAKkklEQVR4nO2deZAeRRmHn4EcEIpDoqAgRYebcF8WR4xQYBXQXHIK4bYCETQgAekIATQozVGiEbnPRQwqBQh0gICAHAVyCFEujUD/hYByxkASIOMfb29cw2bz7e7MfMe8T9VXszszX89vp/Y3fb39TpbnOYqi1INlmi1AUZTqUMMrSo1QwytKjVDDK0qNUMMrSo1QwytKjVDDK0qNUMMrSo1QwytKjVDDK0qNUMNXTZZpLLPSNIY0W0ArYFwYA0wDPgUW9Pi8CJwSvVWTKh1B7Q1vXMiA84ApwCxgWI/PRcABwC1NE6goBVJ7wwNfAxZGb8PiB4wL3wWCcWFG9PbD6qUpSrF0dB/euHCGcWHrpZw2BZja24Ho7d+A24DTi9amKM2gYw1vXDDAd4Au48LySzhnJ2B54A99FDUVOMK4MKpwkYpSMU0xvHFhS+PCSiVf5hTgJ8BdadsbU4CpfQ3KRW8/AM5B+vOK0tY0q4b/NXCXcWFEGYUbFz4P7AtcC5wN7GJc2GWxc74CjATuaaDIXwFrGBd2K1qrolRJ5YY3LqwHzAMeAn5rXBhawmVOBK6L3s6N3s4HjgKuNC6s3OOcM4FzG5lyi94uBCYCF5ekV1EqoRk1/N7AnUjNG4HrjQuF6TAurAAcC1zSvS96Owup7X+WztkKWAu4o9Fyo7dPAX9CHiaK0pY0w/D7AHekmnVi2jctzYcXwbHA76O3/15s/4XAhsaF/ZDa/ccDCKj5AXBy6g4oStuRVZm11rjwOeBZYFS32VIT+Xbg6ejt2anZvUn6bIrECswAHojefrSU8ocCLwG7RW9jL8fXBx4A3gO2SE31/v4N2wK/Ab4XvW24hbCILMvJ86IeborSL6o2/GHA2OjthMX2j0AGz0YB84EXgOfTNgMsEiDzNNIduDN6+2Yv5Y8D9ozejutDw0HAu9Hb+wfxd4xKOi6N3l7ary+r4ZUmUrXhpwM3Rm9n9HJsCDA8ejt3Cd8dCoxBxgD2Q+bOz4vevpqOZ0jr4ajUZy8V48KqSMvkcWByw60FNbzSRCozvHFhGPAasG70dt4gyxqOjLyfBjyGzLOvA5wUvd1jsFr7oWM54AZgIXB0mhHoGzW80kSqHLT7KvDkYM0OEL2dH729EhgNPIw0r28Azh9s2f3UMQ84FHgduLuCYCJFGRRVGn5v+jEN1gjR24+jt9ciA3wHAX8ssvwGNSyM3k5CBhYfNC58sWoNitIolTTpU/96NrBj9Pat0i/YJIwLRyJTdzZ6+0ovx0fH8/d6QZv0SrOoqoYfDbzVyWYHiN52ITH8M1NwD8aFtY0LpxsXZgHXp31jmqdSqTNVGX4fCm7OtyppBmIccKtx4THgbiSZxoHR2+6Ana40n68olVKl4e+s6FpNJ3r7BLAzEoa7SfR2avR2do9TDkbWEWzWDH1KfSm9D29cWB14FNhAc8OxaFouNeu7gD1Sog1g0Uq/g5CYg4nR27ebpFTpQKow/LHA5tHbk0u9ULvQYx4+Lbe9HPgGsDlwGDLe0Z1Db7Xo7VFN0al0JFU06QufjusUUnjvycj9GQtcgAQmnQY4YCPjwhIDiYwLmXHhMuPC48aFY8rKL6B0DqXW8Cn89Flgvejtx6VdqJ3oR6SdcWETJHx3m5R5Z/Hjk4EdkYw845E1B7cDV0Rvny9Ms9IxlF3DHw1MV7MPjOjtC8CNSBrt/8O4sD9wCHBY9PaZtCBpNPBX4Abjwt3GhbUqFay0PKUZPgXbjAeuKOsaNcEDY4wLY7t3GBe2QXLs7Ru9ndO9P3o7J4UcbwvcBDxiXDiyr1wDxoVly5OutBqlNemNC7sCk6K3e5ZygXZlAItnjAvbISP6WwOrIiHEh6fpv76+92XgGuBD4PjuwCfjwmrICzYOSWXumjL6KB1OmYa/BegaUJKITmaAq+WMCxcgKbW3B34avZ3e4Pcy4Hgkt/41SF6BdYFbgZuBEcAvgO2itwv6q0tpL0p584xxYQ1gK6QGUYrhbOA54OZGzQ6QYh8uNy7cBxyRynmi5/p948IjyBqAcwpVrLQcpdTwxoUpQB69PbfwwtudQayHTy/UmFd0AJNxYUXgGST89y9Flq20FoUbPmWu+TuwU/T2n4UW3gm0aAIM48LXkdmA7aO3nzRbj1IOZTTpLfCMmr29iN7eZ1w4BDgVmRmolDTWsDdwFtJ1OT56+2nVOjqdMqblJgCXlVCuUj6nAuONCxv33Jki+kxq+hdKKnt3JOf/BOAEZHXh1UW+r0ARCm3SGxfWAQIwWhfKLIEWbdJ3Y1zYCxnAuxCZz98WSRf+BrAycEL0dmY/ysuAnZABwxx4H0kT/h7yBqJvpe2U6O3j6TvLIinL5gPjB5JOvN1JXeMjgeOQCrSrCE8VbfjzgTeitxcXVmin0eKGBzAunAOsiaQFfwp4Pnq7wLiwKWLEJ4HTorf/6aOM4cgy4JOAuUgA1lxgFeTBsQqwInBX9PYzqcnSP/yNwBxgwkBNnx4eOwNfApbt8RmCpEF/tOwHSloBuTGwUdp2t6BuA26L3v6rx7kZ8l7Ec5GuzWXAZGA40s15dTBaCjO8ceEA4GJgy+jtO4UU2om0geH7IqULPwNJ3jk+evtw2j8MWBuZ498BqZ0eBKZFb58b4LWGIBGDbwMn9qeGMy5sCBwDfBMxzmzgU+CTtF2YdK6LvCy0K3r72kB09nLt5ZGHjAV2BxYgL0h5OW1fApYD9kdSrkfgd2l7FtIKmtx939JD4GBkbOUS4OcDHVgt0vBXAbdEb+8tpMBOpc0N300K770OqYHXAIYi/7CvIPH8XUWkNEsPmOlIDf0qYv530vb9dFqGjEctg7QeDgZWSPpu6lmD9lL+msDhSNrzN4F709/0YfrMRboc3UbJ0ydDTLsCErw0AlgJyWOwFZIDIgD3LOX6GbAdcCCyFuKi6O1DSzh3JBJSvRmSnj0DiN5O7O383ijM8FmWHZfn+ZWFFFYiqrM42kEjqM6eFDkKelyBZZWJ6iyOdtAIqnMROu2hKDVCDa8oNaJIw7d8HymhOoujHTSC6lxEpW+PVRSluWiTXlFqRL8Wz2RZNhZJmvhWnufXZlm2PxK48A8kamkc8C4SHNC9NPaMPM8rXQTRD53XI2miZ+R53lWlxgZ0vgb4PM93z7JsJBLn/lGe5z9qYZ1bIiPNM/M8v72FNL6Xjs1BAnla9V721PkwJdzL/tbwO+R57oEvpN/Xz/P8QmADJKroXCQEcAvgPuD+9HPVNKpzIWL8ZqV3XqLOPM+fAx5K+3cGrgZez7Js1cpVNq5zAfLP2oz72ZfGB5EotZG09r3sqbOUe9lfwy/e4W/VAYCGdOZ5/kGe598GhmdZVvhKsAbotPv5Yp7npwPrlC/ps5dfyu/fB66qSEtfNKSzrHvZr0G71BzZAQlt/DP/i52ejcQHH4rUmL8EpqavndmkJn0jOm9FmverAZPyikcwl6JzFjANifO+H5iENEOn9l5aS+h8EdgLGJbn+Q9bSOPqyKq/mcADtO697KnzZUq4lzpKryg1QkfpFaVGqOEVpUao4RWlRqjhFaVGqOEVpUao4RWlRqjhFaVGqOEVpUao4RWlRqjhFaVGqOEVpUb8F0jyYQBiCuv3AAAAAElFTkSuQmCC"/></td>&#13;
    </tr>&#13;
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0401010ACAAAAAA&amp;denomIds=4.1.1&amp;selectedTab=summary" target="_blank">Sodium oxybate 500mg/ml oral solution sugar free : 6</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0301011E0&amp;denomIds=3.1.1&amp;selectedTab=summary">Formoterol fumarate</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>144</td>&#13;
      <td>Selective beta(2)-agonists</td>&#13;
      <td>3236</td>&#13;
      <td>0.04</td>&#13;
      <td>0.0</td>&#13;
      <td>0.01</td>&#13;
      <td>6.13</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0301011E0AAADAD&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Formoterol 12micrograms/dose inhaler CFC free : 61</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0301011E0BEAAAC&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Formoterol Easyhaler 12micrograms/dose dry powder inhaler : 68</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0301011E0AAAAAA&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Formoterol 12microgram inhalation pdr caps with device : 10</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0301011E0BCABAC&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Oxis 12 Turbohaler : 5</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0601023AH&amp;denomIds=6.1.2&amp;selectedTab=summary">Saxagliptin/metformin</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>28</td>&#13;
      <td>Other antidiabetic drugs</td>&#13;
      <td>1619</td>&#13;
      <td>0.02</td>&#13;
      <td>0.0</td>&#13;
      <td>0.00</td>&#13;
      <td>5.35</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0601023AHAAABAB&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Saxagliptin 2.5mg / Metformin 1g tablets : 23</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0601023AHAAAAAA&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Saxagliptin 2.5mg / Metformin 850mg tablets : 5</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0601023AL&amp;denomIds=6.1.2&amp;selectedTab=summary">Dapagliflozin/metformin</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>94</td>&#13;
      <td>Other antidiabetic drugs</td>&#13;
      <td>1619</td>&#13;
      <td>0.06</td>&#13;
      <td>0.0</td>&#13;
      <td>0.01</td>&#13;
      <td>5.00</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0601023ALAAABAB&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Dapagliflozin 5mg / Metformin 1g tablets : 94</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=1104020AB&amp;denomIds=11.4.2&amp;selectedTab=summary">Hamamalis</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>3</td>&#13;
      <td>Other anti-inflammatory preparations</td>&#13;
      <td>76</td>&#13;
      <td>0.04</td>&#13;
      <td>0.0</td>&#13;
      <td>0.01</td>&#13;
      <td>4.89</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=1104020ABBCACAB&amp;denomIds=11.4.2&amp;selectedTab=summary" target="_blank">Optrex Sore Eyes 13% eye drops : 3</a></div></td></tr></tbody></table>&#13;
&#13;
        <h2>Prescribing where Eskdaill Medical is lower than most</h2>&#13;
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">&#13;
  <thead>&#13;
    &#13;
    &#13;
  <tr><th>BNF Chemical</th>&#13;
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>&#13;
      <th>BNF Subparagraph</th>&#13;
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>&#13;
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>&#13;
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>&#13;
      <th><abbr title="Standard Deviation">std</abbr></th>&#13;
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>&#13;
      <th>Plots</th>&#13;
    </tr></thead>&#13;
  &#13;
<tbody><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0703010F0&amp;denomIds=7.3.1&amp;selectedTab=summary">Combined ethinylestradiol 30mcg</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>140</td>&#13;
      <td>Combined hormonal contraceptives</td>&#13;
      <td>219</td>&#13;
      <td>0.64</td>&#13;
      <td>0.81</td>&#13;
      <td>0.07</td>&#13;
      <td>-2.30</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0703010F0BPAAAC&amp;denomIds=7.3.1&amp;selectedTab=summary" target="_blank">Rigevidon tablets : 67</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0703010F0BTAAAA&amp;denomIds=7.3.1&amp;selectedTab=summary" target="_blank">Cimizt 30microgram/150microgram tablets : 2</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0703010F0BBAAAA&amp;denomIds=7.3.1&amp;selectedTab=summary" target="_blank">Marvelon tablets : 1</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0703010F0BEABAH&amp;denomIds=7.3.1&amp;selectedTab=summary" target="_blank">Microgynon 30 ED tablets : 1</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0703010F0BJAAAE&amp;denomIds=7.3.1&amp;selectedTab=summary" target="_blank">Femodene tablets : 1</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0703010F0BQAAAA&amp;denomIds=7.3.1&amp;selectedTab=summary" target="_blank">Gedarel 30microgram/150microgram tablets : 1</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0703010F0BVAAAJ&amp;denomIds=7.3.1&amp;selectedTab=summary" target="_blank">Lucette 0.03mg/3mg tablets : 1</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0703010F0BLAAAJ&amp;denomIds=7.3.1&amp;selectedTab=summary" target="_blank">Yasmin tablets : 3</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0703010F0BNAAAC&amp;denomIds=7.3.1&amp;selectedTab=summary" target="_blank">Levest 150/30 tablets (Morningside) : 26</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0703010F0CEAAAJ&amp;denomIds=7.3.1&amp;selectedTab=summary" target="_blank">Dretine 0.03mg/3mg tablets : 16</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0703010F0BRAAAE&amp;denomIds=7.3.1&amp;selectedTab=summary" target="_blank">Millinette 30microgram/75microgram tablets : 11</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0703010F0BEAAAC&amp;denomIds=7.3.1&amp;selectedTab=summary" target="_blank">Microgynon 30 tablets : 10</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=1307000M0&amp;denomIds=13.7&amp;selectedTab=summary">Salicylic acid</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>0</td>&#13;
      <td>Preparations for warts and calluses</td>&#13;
      <td>5</td>&#13;
      <td>0.00</td>&#13;
      <td>0.69</td>&#13;
      <td>0.31</td>&#13;
      <td>-2.20</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div/></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0301011R0&amp;denomIds=3.1.1&amp;selectedTab=summary">Salbutamol</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>2611</td>&#13;
      <td>Selective beta(2)-agonists</td>&#13;
      <td>3236</td>&#13;
      <td>0.81</td>&#13;
      <td>0.91</td>&#13;
      <td>0.05</td>&#13;
      <td>-2.17</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0301011R0AAAPAP&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salbutamol 100micrograms/dose inhaler CFC free : 1169</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0301011R0AABUBU&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salbutamol 100micrograms/dose breath actuated inh CFC free : 51</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0301011R0BEAIAP&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Ventolin 100micrograms/dose Evohaler : 1141</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0301011R0BEANAX&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Ventolin 2.5mg Nebules : 45</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0301011R0BIAGBU&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salamol 100micrograms/dose Easi-Breathe inhaler : 93</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0301011R0BMABBU&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Airomir 100micrograms/dose Autohaler : 2</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0301011R0BWABAQ&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Easyhaler Salbutamol sulfate 200micrograms/dose dry pdr inh : 1</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0301011R0AAAXAX&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials : 28</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0301011R0BEAHAQ&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Ventolin 200micrograms/dose Accuhaler : 9</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0301011R0BIAFAP&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salamol 100micrograms/dose inhaler CFC free (Teva) : 23</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0301011R0BEAXBD&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Ventolin 5mg Nebules : 8</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0301011R0AABDBD&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salbutamol 5mg/2.5ml nebuliser liquid unit dose vials : 11</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0301011R0BWAABZ&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Easyhaler Salbutamol sulfate 100micrograms/dose dry pdr inh : 25</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0301011R0AABGBG&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salbutamol 2mg/5ml oral solution sugar free : 5</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=1105000B0&amp;denomIds=11.5&amp;selectedTab=summary">Atropine sulfate</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>0</td>&#13;
      <td>Mydriatics and cycloplegics</td>&#13;
      <td>9</td>&#13;
      <td>0.00</td>&#13;
      <td>0.72</td>&#13;
      <td>0.38</td>&#13;
      <td>-1.91</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div/></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0906040G0&amp;denomIds=9.6.4&amp;selectedTab=summary">Colecalciferol</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>1496</td>&#13;
      <td>Vitamin D</td>&#13;
      <td>1633</td>&#13;
      <td>0.92</td>&#13;
      <td>0.96</td>&#13;
      <td>0.02</td>&#13;
      <td>-1.90</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0906040G0BKAABS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Accrete D3 tablets : 108</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0906040G0BNAABY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Adcal-D3 chewable tablets tutti frutti : 102</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0906040G0BNABBY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Adcal-D3 Lemon chewable tablets : 35</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0906040G0BNACCB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Adcal-D3 Dissolve 1500mg/400unit effervescent tablets : 49</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0906040G0BNADCD&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Adcal-D3 750mg/200unit caplets : 76</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0906040G0BXAAAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Fultium-D3 800unit capsules : 57</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0906040G0CWAABY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Evacal D3 1500mg/400unit chewable tablets : 819</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0906040G0DFACDU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 50,000units/1ml oral solution : 48</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0906040G0AADKDK&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 25,000unit tablets : 2</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0906040G0DFAEBI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 400unit capsules : 2</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0906040G0AABHBH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 1,000unit capsules : 1</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0906040G0AACRCR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 20,000unit tablets : 1</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0906040G0AADUDU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 50,000units/1ml soln ud amp sugar free : 1</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0906040G0CHABBG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 1,000unit tablets : 1</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0906040G0CHAJDS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 3,000units/ml liquid : 1</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0906040G0CHAKCU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 2,000units/ml liquid : 1</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0906040G0DBAACN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Vitamin D3 High Strength 5,000unit tablets : 1</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0906040G0CGAADR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Hux D3 20,000unit capsules : 14</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0906040G0AAEJEJ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 5,600unit capsules : 4</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0906040G0BRAABU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calcichew D3 chewable tablets : 4</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0906040G0BXABDF&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Fultium-D3 3,200unit capsules : 4</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0906040G0AABYBY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.5g chewable tab : 13</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0906040G0BRABBW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calcichew D3 Forte chewable tablets : 3</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0906040G0AABWBW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.25g chew tab : 12</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0906040G0AAANAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 800unit capsules : 26</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0906040G0AACNCN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 5,000unit tablets : 7</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0906040G0DFAADH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 25,000units/1ml oral solution : 16</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0906040G0AACBCB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.5g efferv tab : 11</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0906040G0CJAACS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Desunin 800unit tablets : 11</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0906040G0DFAFEQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 50,000unit capsules : 11</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0906040G0BQAABW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calceos 500mg/400unit chewable tablets : 20</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0906040G0DFADAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 800unit capsules : 15</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0906040G0AACSCS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 800unit tablets : 10</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0906040G0AADLDL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 800unit / Calcium carbonate 2.5g chewable tab : 5</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=K83013&amp;numIds=0906040G0DFAGEK&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 25,000unit capsules : 5</a></div></td></tr></tbody></table>&#13;
&#13;
    </div><script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"/>&#13;
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"/>&#13;
</body>&#13;
&#13;
</html>